For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Acea Biosciences, Inc.

Calculating rank

USPTO Granted Patents = 49

% Expired Patents = 22.4

CIPO Patents = 3

EPO Patents = 14

Trademarks = 15

Forward Citations = 829

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Xiaobo Wang (47 out of 81 patents)

Xiao Xu (39 out of 56 patents)

Yama A Abassi (28 out of 34 patents)

4. Biao Xi (12 out of 20 patents)

5. Nan Li (12 out of 19 patents)

6. Li Zhao (8 out of 15 patents)

7. Josephine Atienza (8 out of 8 patents)

8. Long Mao (6 out of 25 patents)

9. Wen Fu Zhang (5 out of 7 patents)

10. Tianxing Wang (5 out of 7 patents)

11. Ye Chen (5 out of 39 patents)

12. Naichen Yu (5 out of 5 patents)

13. Jiangbo Gan (4 out of 5 patents)

14. Haoyun An (4 out of 22 patents)

15. Jian Wu (3 out of 31 patents)

Core Competencies:

Cell-Substrate Impedance

Real-Time Monitoring

Impedance-Based Assays

Cardiomyocyte Function

Oncogene Inhibitors

Flow Cytometry

G-Protein Coupled Receptors

Receptor Tyrosine Kinase

Cytotoxicity Profiling

Microelectronic Sensing

Electroporation Delivery

Heterocyclic Compounds

49 patents: Sort by Forward Citations

1. 10725023 - Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways for the treatment of cancer (2020-07-28),

2. 10690677 - Real time electronic cell sensing systems and applications for cell-based assays (2020-06-23),

3. 10648913 - System and method for detecting multiple-excitation-induced light in a flow channel (2020-05-12),

4. 10620188 - Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways (2020-04-14),

5. 10551371 - System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function (2020-02-04),

6. 10539523 - System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties (2020-01-21),

7. 10533985 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2020-01-14),

8. 10261080 - Optical detection system for flow cytometer, flow cytometer system and methods of use (2019-04-16),

9. 10234392 - Optical engine for flow cytometer, flow cytometer system and methods of use (2019-03-19),

10. 10215748 - Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways (2019-02-26),

11. 10168318 - Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways (2019-01-01),

12. 10067121 - Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology (2018-09-04),

13. 10018581 - Impedance based devices and methods for use in assays (2018-07-10),

14. 10012636 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2018-07-03),

15. 9920074 - Heterocyclic compounds and uses thereof (2018-03-20),

Company Overview

Acea Biosciences, Inc., based in San Diego, CA, specializes in advanced cell analysis technologies, focusing on real-time electronic cell sensing and impedance-based cell profiling. The company develops innovative solutions for monitoring cellular behavior, particularly in the context of G-Protein Coupled Receptors and Receptor Tyrosine Kinases. Their expertise extends to applications in flow cytometry and cardiomyocyte monitoring, enhancing research capabilities in drug discovery and cellular therapies through precise and dynamic measurement techniques.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

49 Patents

#125 in San Diego, CA

#1,686 in California

#7,154 in US

#14,301 in the World

San Diego, CA, United States of America

Acea Biosciences, Inc.

Forward Citations = 829

33 inventors:

Xiaobo Wang (47 out of 81 patents)

Xiao Xu (39 out of 56 patents)

Yama A Abassi (28 out of 34 patents)

4. Biao Xi (12 out of 20 patents)

5. Nan Li (12 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Acea Biosciences, Inc.. Retrieved from https://idiyas.com/company/acea-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…